Literature DB >> 28280884

Social defeat disrupts reward learning and potentiates striatal nociceptin/orphanin FQ mRNA in rats.

Andre Der-Avakian1, Manoranjan S D'Souza2, David N Potter3,4, Elena H Chartoff3,4, William A Carlezon3,4, Diego A Pizzagalli5,6, Athina Markou7.   

Abstract

RATIONALE: Mood disorders can be triggered by stress and are characterized by deficits in reward processing, including disrupted reward learning (the ability to modulate behavior according to past rewards). Reward learning is regulated by the anterior cingulate cortex (ACC) and striatal circuits, both of which are implicated in the pathophysiology of mood disorders.
OBJECTIVES: Here, we assessed in rats the effects of a potent stressor (social defeat) on reward learning and gene expression in the ACC, ventral tegmental area (VTA), and striatum.
METHODS: Adult male Wistar rats were trained on an operant probabilistic reward task (PRT) and then exposed to 3 days of social defeat before assessment of reward learning. After testing, the ACC, VTA, and striatum were dissected, and expression of genes previously implicated in stress was assessed. RESULT: Social defeat blunted reward learning (manifested as reduced response bias toward a more frequently rewarded stimulus) and was associated with increased nociceptin/orphanin FQ (N/OFQ) peptide mRNA levels in the striatum and decreased Fos mRNA levels in the VTA. Moreover, N/OFQ peptide and nociceptin receptor mRNA levels in the ACC, VTA and striatum were inversely related to reward learning.
CONCLUSIONS: The behavioral findings parallel previous data in humans, suggesting that stress similarly disrupts reward learning in both species. Increased striatal N/OFQ mRNA in stressed rats characterized by impaired reward learning is consistent with accumulating evidence that antagonism of nociceptin receptors, which bind N/OFQ, has antidepressant-like effects. These results raise the possibility that nociceptin systems represent a molecular substrate through which stress produces reward learning deficits in mood disorders.

Entities:  

Keywords:  Anhedonia; Depression; Nucleus accumbens; Opioid; Reward; Stress

Mesh:

Substances:

Year:  2017        PMID: 28280884      PMCID: PMC5420477          DOI: 10.1007/s00213-017-4584-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  73 in total

1.  Causal relationship between stressful life events and the onset of major depression.

Authors:  K S Kendler; L M Karkowski; C A Prescott
Journal:  Am J Psychiatry       Date:  1999-06       Impact factor: 18.112

Review 2.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

3.  Acute stress reduces reward responsiveness: implications for depression.

Authors:  Ryan Bogdan; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2006-06-27       Impact factor: 13.382

4.  Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors.

Authors:  E Venzala; A L García-García; N Elizalde; P Delagrange; R M Tordera
Journal:  Psychopharmacology (Berl)       Date:  2012-06-16       Impact factor: 4.530

5.  The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat.

Authors:  L W Swanson
Journal:  Brain Res Bull       Date:  1982 Jul-Dec       Impact factor: 4.077

6.  Deficits in sustaining reward responses in subsyndromal and syndromal major depression.

Authors:  Wen-hua Liu; Raymond C K Chan; Ling-zhi Wang; Jia Huang; Eric F C Cheung; Qi-yong Gong; Jackie K Gollan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-03-01       Impact factor: 5.067

7.  Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding.

Authors:  C R Neal; A Mansour; R Reinscheid; H P Nothacker; O Civelli; H Akil; S J Watson
Journal:  J Comp Neurol       Date:  1999-10-04       Impact factor: 3.215

8.  Individual differences in reinforcement learning: behavioral, electrophysiological, and neuroimaging correlates.

Authors:  Diane L Santesso; Daniel G Dillon; Jeffrey L Birk; Avram J Holmes; Elena Goetz; Ryan Bogdan; Diego A Pizzagalli
Journal:  Neuroimage       Date:  2008-07-02       Impact factor: 6.556

9.  Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam.

Authors:  Rafal Rygula; Nashat Abumaria; Ursula Havemann-Reinecke; Eckart Rüther; Christoph Hiemke; Gerald Zernig; Eberhard Fuchs; Gabriele Flügge
Journal:  Behav Pharmacol       Date:  2008-05       Impact factor: 2.293

10.  Assessment of reward responsiveness in the response bias probabilistic reward task in rats: implications for cross-species translational research.

Authors:  A Der-Avakian; M S D'Souza; D A Pizzagalli; A Markou
Journal:  Transl Psychiatry       Date:  2013-08-27       Impact factor: 6.222

View more
  21 in total

Review 1.  Metabotropic Glutamate Receptor 5 as a Target for the Treatment of Depression and Smoking: Robust Preclinical Data but Inconclusive Clinical Efficacy.

Authors:  Samuel A Barnes; Douglas J Sheffler; Svetlana Semenova; Nicholas D P Cosford; Anton Bespalov
Journal:  Biol Psychiatry       Date:  2018-03-09       Impact factor: 13.382

Review 2.  Preclinical Models to Investigate Mechanisms of Negative Symptoms in Schizophrenia.

Authors:  Samuel A Barnes; Andre Der-Avakian; Jared W Young
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

3.  Investigating dopamine and glucocorticoid systems as underlying mechanisms of anhedonia.

Authors:  Steven J Lamontagne; Sofia I Melendez; Mary C Olmstead
Journal:  Psychopharmacology (Berl)       Date:  2018-08-22       Impact factor: 4.530

4.  A Paranigral VTA Nociceptin Circuit that Constrains Motivation for Reward.

Authors:  Kyle E Parker; Christian E Pedersen; Adrian M Gomez; Skylar M Spangler; Marie C Walicki; Shelley Y Feng; Sarah L Stewart; James M Otis; Ream Al-Hasani; Jordan G McCall; Kristina Sakers; Dionnet L Bhatti; Bryan A Copits; Robert W Gereau; Thomas Jhou; Thomas J Kash; Joseph D Dougherty; Garret D Stuber; Michael R Bruchas
Journal:  Cell       Date:  2019-07-25       Impact factor: 41.582

5.  Attenuated dopamine receptor signaling in nucleus accumbens core in a rat model of chemically-induced neuropathy.

Authors:  Dana E Selley; Matthew F Lazenka; Laura J Sim-Selley; Julie R Secor McVoy; David N Potter; Elena H Chartoff; William A Carlezon; S Stevens Negus
Journal:  Neuropharmacology       Date:  2020-01-07       Impact factor: 5.250

6.  Decreased Nociceptin Receptors Are Related to Resilience and Recovery in College Women Who Have Experienced Sexual Violence: Therapeutic Implications for Posttraumatic Stress Disorder.

Authors:  Rajesh Narendran; Savannah Tollefson; Kelli Fasenmyer; Jennifer Paris; Michael L Himes; Brian Lopresti; Roberto Ciccocioppo; N Scott Mason
Journal:  Biol Psychiatry       Date:  2019-04-04       Impact factor: 13.382

7.  Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress.

Authors:  Aldemara I Silva; Victor A D Holanda; Joaquim G Azevedo Neto; Edilson D Silva Junior; Vanessa P Soares-Rachetti; Girolamo Calo; Chiara Ruzza; Elaine C Gavioli
Journal:  Psychopharmacology (Berl)       Date:  2020-02-24       Impact factor: 4.530

8.  Brain mechanisms mediating effects of stress on reward sensitivity.

Authors:  Maria Ironside; Poornima Kumar; Min-Su Kang; Diego A Pizzagalli
Journal:  Curr Opin Behav Sci       Date:  2018-02-22

Review 9.  Translational Assessments of Reward and Anhedonia: A Tribute to Athina Markou.

Authors:  Andre Der-Avakian; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2018-02-24       Impact factor: 13.382

10.  Translational Assessments of Reward Responsiveness in the Marmoset.

Authors:  Lisa M Wooldridge; Jack Bergman; Diego A Pizzagalli; Brian D Kangas
Journal:  Int J Neuropsychopharmacol       Date:  2021-05-18       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.